Broglio KR - Search Results

1

Addressing the incremental benefit of histamine dihydrochloride when added to interleukin-2 in treating acute myeloid leukemia: a Bayesian meta-analysis.

Berry SM, Broglio KR, Berry DA. Berry SM, et al. Among authors: broglio kr. Cancer Invest. 2011 May;29(4):293-9. doi: 10.3109/07357907.2011.568563. Cancer Invest. 2011. PMID: 21469978

2

Detecting an overall survival benefit that is derived from progression-free survival.

Broglio KR, Berry DA. Broglio KR, et al. J Natl Cancer Inst. 2009 Dec 2;101(23):1642-9. doi: 10.1093/jnci/djp369. Epub 2009 Nov 9. J Natl Cancer Inst. 2009. PMID: 19903805 Free PMC article.

3

Predicting clinical trial results based on announcements of interim analyses.

Broglio KR, Stivers DN, Berry DA. Broglio KR, et al. Trials. 2014 Mar 7;15:73. doi: 10.1186/1745-6215-15-73. Trials. 2014. PMID: 24607270 Free PMC article.

4

Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis.

Broglio KR, Quintana M, Foster M, Olinger M, McGlothlin A, Berry SM, Boileau JF, Brezden-Masley C, Chia S, Dent S, Gelmon K, Paterson A, Rayson D, Berry DA. Broglio KR, et al. JAMA Oncol. 2016 Jun 1;2(6):751-60. doi: 10.1001/jamaoncol.2015.6113. JAMA Oncol. 2016. PMID: 26914222

5

A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression.

Berry SM, Broglio K, Bunker M, Jayewardene A, Olin B, Rush AJ. Berry SM, et al. Med Devices (Auckl). 2013;6:17-35. doi: 10.2147/MDER.S41017. Epub 2013 Mar 1. Med Devices (Auckl). 2013. PMID: 23482508 Free PMC article.

6

Bayesian adaptive design for clinical trials in Duchenne muscular dystrophy.

Lake SL, Quintana MA, Broglio K, Panagoulias J, Berry SM, Panzara MA. Lake SL, et al. Stat Med. 2021 Aug 30;40(19):4167-4184. doi: 10.1002/sim.9021. Epub 2021 May 7. Stat Med. 2021. PMID: 33960507

7

Comparison of Bayesian vs Frequentist Adaptive Trial Design in the Stroke Hyperglycemia Insulin Network Effort Trial.

Broglio K, Meurer WJ, Durkalski V, Pauls Q, Connor J, Berry D, Lewis RJ, Johnston KC, Barsan WG. Broglio K, et al. JAMA Netw Open. 2022 May 2;5(5):e2211616. doi: 10.1001/jamanetworkopen.2022.11616. JAMA Netw Open. 2022. PMID: 35544137 Free PMC article. Clinical Trial.

8

PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design.

Broglio K, Kostakoglu L, Ward C, Mattiello F, Sahin D, Nielsen T, McGlothlin A, Elliott CF, Witzig T, Sehn LH, Trnĕný M, Vitolo U, Martelli M, Foster M, Wendelberger B, Nowakowski G, Berry DA. Broglio K, et al. Leuk Lymphoma. 2022 Dec;63(12):2816-2831. doi: 10.1080/10428194.2022.2095624. Epub 2022 Jul 11. Leuk Lymphoma. 2022. PMID: 35815677

9

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.

Lewis EC, Kraveka JM, Ferguson W, Eslin D, Brown VI, Bergendahl G, Roberts W, Wada RK, Oesterheld J, Mitchell D, Foley J, Zage P, Rawwas J, Rich M, Lorenzi E, Broglio K, Berry D, Saulnier Sholler GL. Lewis EC, et al. Int J Cancer. 2020 Dec 1;147(11):3152-3159. doi: 10.1002/ijc.33044. Epub 2020 May 24. Int J Cancer. 2020. PMID: 32391579 Free PMC article. Clinical Trial.

10

Combining risk difference and risk ratio in noninferiority trials of safety.

Broglio KR, Connor JT, Berry SM. Broglio KR, et al. J Biopharm Stat. 2013;23(1):261-71. doi: 10.1080/10543406.2011.616966. J Biopharm Stat. 2013. PMID: 23331235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters